Market Cap 526.18M
Revenue (ttm) 240.98M
Net Income (ttm) -1.97M
EPS (ttm) N/A
PE Ratio 13.50
Forward PE 12.92
Profit Margin -0.82%
Debt to Equity Ratio 0.89
Volume 91,300
Avg Vol 91,506
Day's Range N/A - N/A
Shares Out 5.53M
Stochastic %K 83%
Beta 0.89
Analysts Sell
Price Target $104.50

Company Profile

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also pro...

Industry: Scientific & Technical Instruments
Sector: Technology
Phone: 303 987 8000
Address:
12100 West Sixth Avenue, Lakewood, United States
PenkeInvesting
PenkeInvesting Feb. 26 at 3:27 PM
Fundamental analysis of $MLAB (MESA LABORATORIES INC /CO/) based on financial data and reported results. #MLAB
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 25 at 3:28 PM
0 · Reply
VolatilityDispersion
VolatilityDispersion Feb. 20 at 1:39 PM
$MLAB Mesa Laboratories supplies calibration and quality control tools. Recurring revenue supports margins. Growth depends on regulated industries.
0 · Reply
IdaLarsen905
IdaLarsen905 Feb. 18 at 1:40 PM
$MLAB Diagnostic instruments firm with steady demand.
0 · Reply
DylanHarman593
DylanHarman593 Feb. 11 at 3:52 PM
$MLAB Mesa Labs; life sciences tools (sterilization monitoring); steady grower; tied to biopharma and healthcare capital spending.
0 · Reply
IN0V8
IN0V8 Feb. 4 at 7:45 PM
$MLAB Wells Fargo raises target price to $94 from $83
0 · Reply
erevnon
erevnon Feb. 4 at 3:59 PM
Wells Fargo maintains Mesa Laboratories $MLAB at Equal-Weight and raises the price target from $83 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 16 at 5:09 AM
$MLAB Current Stock Price: $87.66
0 · Reply
BearTamerTrading
BearTamerTrading Jan. 11 at 11:57 PM
On Watch for JPM Week: Part 2 $MLAB – Mesa Labs – will present on Jan 14, 2026. $AAPG – Ascentage Pharma Group International – announced presentation. $LFCR – Lifecore Biomedical – participating (1-on-1s and meetings).
0 · Reply
ProximityPro
ProximityPro Dec. 26 at 2:23 PM
$MLAB Market structure is quietly punishing unfocused strategies. Efficiency initiatives must translate into measurable productivity. Evidence of repeatability is likely to change market tone. Stronger outcomes appear only when priorities stay focused.
0 · Reply
Latest News on MLAB
MESA LABS DECLARES QUARTERLY DIVIDEND

Jan 7, 2026, 5:00 PM EST - 7 weeks ago

MESA LABS DECLARES QUARTERLY DIVIDEND


Mesa Labs Announces First Quarter Results

Aug 5, 2025, 8:00 AM EDT - 7 months ago

Mesa Labs Announces First Quarter Results


Mesa Labs Announces Third Quarter Results

Feb 4, 2025, 8:00 AM EST - 1 year ago

Mesa Labs Announces Third Quarter Results


Mesa Labs Announces Second Quarter Results

Nov 7, 2024, 8:00 AM EST - 1 year ago

Mesa Labs Announces Second Quarter Results


Mesa Labs Declares Quarterly Dividend

Jan 3, 2023, 5:00 PM EST - 3 years ago

Mesa Labs Declares Quarterly Dividend


Mesa Labs Acquires Belyntic's Peptide Purification Business

Nov 17, 2022, 8:04 AM EST - 3 years ago

Mesa Labs Acquires Belyntic's Peptide Purification Business


Mesa Labs Reports Fourth Quarter and Full Fiscal Year Results

May 31, 2022, 8:00 AM EDT - 4 years ago

Mesa Labs Reports Fourth Quarter and Full Fiscal Year Results


Mesa Labs Closes Acquisition of Agena Bioscience

Oct 20, 2021, 12:05 PM EDT - 4 years ago

Mesa Labs Closes Acquisition of Agena Bioscience


Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc.

Sep 14, 2021, 7:00 AM EDT - 4 years ago

Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc.


Mesa Laboratories: Q4 Earnings Insights

Jun 1, 2021, 9:56 AM EDT - 5 years ago

Mesa Laboratories: Q4 Earnings Insights


Mesa Labs Reports Third Quarter Results for FY21

Feb 3, 2021, 8:00 AM EST - 5 years ago

Mesa Labs Reports Third Quarter Results for FY21


Mesa Labs Reports Second Quarter Results for FY21

Nov 5, 2020, 8:00 AM EST - 5 years ago

Mesa Labs Reports Second Quarter Results for FY21


Mesa Labs Reports First Quarter Results

Aug 6, 2020, 8:00 AM EDT - 6 years ago

Mesa Labs Reports First Quarter Results


Recap: Mesa Laboratories Q4 Earnings

Jun 1, 2020, 8:07 AM EDT - 6 years ago

Recap: Mesa Laboratories Q4 Earnings


MESA LABS DECLARES  QUARTERLY DIVIDEND

Jan 9, 2020, 7:00 PM EST - 6 years ago

MESA LABS DECLARES QUARTERLY DIVIDEND


Mesa Labs Acquires Gyros Protein Technologies

Oct 31, 2019, 8:55 PM EDT - 6 years ago

Mesa Labs Acquires Gyros Protein Technologies


PenkeInvesting
PenkeInvesting Feb. 26 at 3:27 PM
Fundamental analysis of $MLAB (MESA LABORATORIES INC /CO/) based on financial data and reported results. #MLAB
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 25 at 3:28 PM
0 · Reply
VolatilityDispersion
VolatilityDispersion Feb. 20 at 1:39 PM
$MLAB Mesa Laboratories supplies calibration and quality control tools. Recurring revenue supports margins. Growth depends on regulated industries.
0 · Reply
IdaLarsen905
IdaLarsen905 Feb. 18 at 1:40 PM
$MLAB Diagnostic instruments firm with steady demand.
0 · Reply
DylanHarman593
DylanHarman593 Feb. 11 at 3:52 PM
$MLAB Mesa Labs; life sciences tools (sterilization monitoring); steady grower; tied to biopharma and healthcare capital spending.
0 · Reply
IN0V8
IN0V8 Feb. 4 at 7:45 PM
$MLAB Wells Fargo raises target price to $94 from $83
0 · Reply
erevnon
erevnon Feb. 4 at 3:59 PM
Wells Fargo maintains Mesa Laboratories $MLAB at Equal-Weight and raises the price target from $83 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 16 at 5:09 AM
$MLAB Current Stock Price: $87.66
0 · Reply
BearTamerTrading
BearTamerTrading Jan. 11 at 11:57 PM
On Watch for JPM Week: Part 2 $MLAB – Mesa Labs – will present on Jan 14, 2026. $AAPG – Ascentage Pharma Group International – announced presentation. $LFCR – Lifecore Biomedical – participating (1-on-1s and meetings).
0 · Reply
ProximityPro
ProximityPro Dec. 26 at 2:23 PM
$MLAB Market structure is quietly punishing unfocused strategies. Efficiency initiatives must translate into measurable productivity. Evidence of repeatability is likely to change market tone. Stronger outcomes appear only when priorities stay focused.
0 · Reply
erevnon
erevnon Dec. 15 at 7:50 PM
Wells Fargo maintains Mesa Laboratories $MLAB at Equal-Weight and raises the price target from $75 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
JarvisFlow
JarvisFlow Dec. 15 at 6:27 PM
Wells Fargo has adjusted their stance on Mesa Laboratories ( $MLAB ), setting the rating to Equal-Weight with a target price of 75 → 83.
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 11 at 10:55 AM
0 · Reply
UsernameInUse
UsernameInUse Nov. 25 at 8:39 PM
$MLAB let's make few bucks here with 20k
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 14 at 6:44 PM
0 · Reply
Estimize
Estimize Nov. 11 at 9:00 PM
Wall St is expecting 1.40 EPS for $MLAB Q3 [Reporting 02/09 AMC] http://www.estimize.com/intro/mlab?chart=historical&metric_name=eps&utm_co
0 · Reply
IN0V8
IN0V8 Nov. 10 at 5:38 PM
$MLAB Jefferies raises target price to $115 from $110
0 · Reply
anvesti
anvesti Oct. 22 at 2:43 AM
0 · Reply
PatternCrawler
PatternCrawler Oct. 5 at 12:03 PM
$MLAB Technology hardware micro-cap. No clear pattern. Illiquid conditions. Avoid.
0 · Reply
Twinturbos
Twinturbos Oct. 2 at 2:35 PM
0 · Reply
Twinturbos
Twinturbos Sep. 25 at 2:51 AM
$MLAB 👀
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 9 at 12:43 PM
$MLAB Brilliant piece that captures MLAB's situation perfectly. So if you want to update your understanding of MLAB or get to know MLAB better, this is essential reading. https://beyondspx.com/quote/MLAB/analysis/mesa-labs-niche-leadership-and-operational-improvement-drive-growth-amidst-macro-headwinds-mlab
0 · Reply